These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2132640)

  • 1. Phosphatidylserine: quantitative EEG effects in healthy volunteers.
    Rosadini G; Sannita WG; Nobili F; Cenacchi T
    Neuropsychobiology; 1990-1991; 24(1):42-8. PubMed ID: 2132640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative EEG effects and drug plasma concentration of phenobarbital, 50 and 100 mg single-dose oral administration to healthy volunteers: evidence of early CNS bioavailability.
    Sannita WG; Balbi A; Giacchino F; Rosadini G
    Neuropsychobiology; 1990-1991; 23(4):205-12. PubMed ID: 2130290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers.
    Sannita WG; Maggi L; Rosadini G
    Neuropsychobiology; 1987; 17(4):199-205. PubMed ID: 3441275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG and neuropsychological effects of piracetam and of the association piracetam-lecithin in healthy volunteers.
    Sannita WG; Balestra V; Rosadini G; Salama M; Timitilli C
    Neuropsychobiology; 1985; 14(4):203-9. PubMed ID: 3835497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
    Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
    J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG changes following scopolamine administration in healthy subjects. Quantitative analysis during rest and photic stimulation.
    Kikuchi M; Wada Y; Nanbu Y; Nakajima A; Tachibana H; Takeda T; Hashimoto T
    Neuropsychobiology; 1999 May; 39(4):219-26. PubMed ID: 10343188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG and behavioral effects of pirenzepine in normal volunteers.
    Fink M; Irwin P
    Scand J Gastroenterol Suppl; 1980; 66():39-46. PubMed ID: 6941376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and electroencephalographic effects of darodipine 50-200 mg modified release (MR) acute oral administration: dose-finding study in healthy volunteers.
    Sannita WG; Busico S; Di Bon G; Ferrari A; Riela S
    Int J Clin Pharmacol Res; 1993; 13(5):281-91. PubMed ID: 8200723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative topographical electroencephalographic analysis after intravenous clonidine in healthy male volunteers.
    Bischoff P; Mahlstedt D; Blanc I; Schulte am Esch J
    Anesth Analg; 1998 Jan; 86(1):202-7. PubMed ID: 9428879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaco-EEG mapping of diazepam effects using different references and absolute and relative power.
    Yamadera H; Kato M; Ueno T; Tsukahara Y; Okuma T
    Pharmacopsychiatry; 1993 Nov; 26(6):254-8. PubMed ID: 8127930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ammonia-independent modifications of the background EEG signal and paradoxical enhancement of epileptic abnormalities in EEG after acute administration of valproate to epileptic patients.
    Sannita WG; Balestra V; DiBon G; Hassan KM; Rosadini G
    Neuropharmacology; 1993 Sep; 32(9):919-28. PubMed ID: 8232792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative EEG and behavioral effects in volunteers of a new benzodiazepine (SAS 643) in relation to drug plasma concentration.
    Sannita WG; Cabri M; Montano VF; Rosadini G
    Ther Drug Monit; 1981; 3(4):341-9. PubMed ID: 6121403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.